HUMPHREY RACHEL
SEC insider (Form 3/4/5 filer). CIK 0001579781. Director at Pyxis Oncology, Inc. (PYXS). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 24, 2026. Located in BOSTON, MA.
Companies HUMPHREY RACHEL has filed insider reports for
- Pyxis Oncology, Inc. (PYXS): Director
HUMPHREY RACHEL
CIK: 0001579781
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PYXS
Pyxis Oncology, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 24, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
45.9K shares- - Apr 21, 2025PYXS
Pyxis Oncology, Inc.
SaleDirect13.9K shares at avg. $1.03$14K - Apr 17, 2025PYXS
Pyxis Oncology, Inc.
SaleDirect200 shares at avg. $0.97$194 - Apr 14, 2025PYXS
Pyxis Oncology, Inc.
SaleDirect1.4K shares at avg. $0.97$1K - Mar 31, 2025PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
37K shares at avg. $0.98-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 24, 2026 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 45,867 | - | - | Direct |
| Apr 21, 2025 | PYXS Pyxis Oncology, Inc. | Sale | 13,896 | $1.03 | $14,362 | Direct |
| Apr 17, 2025 | PYXS Pyxis Oncology, Inc. | Sale | 200 | $0.97 | $194 | Direct |
| Apr 14, 2025 | PYXS Pyxis Oncology, Inc. | Sale | 1,400 | $0.97 | $1,362 | Direct |
| Mar 31, 2025 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 36,979 | $0.98 | - | Direct |
1-5 of 5 transactions